https://www.nejm.org/doi/pdf/10.1056/NEJMoa2301972
0
0
Triple–Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial | NEJM - nejm.org
6/26/23 at 9:07pm
Organization
nejm.org
Author
nejm.org
Details
14 words
Summarize
Create an account or login to join the discussion